Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it? Sources point to a single instance in which experimental therapy retatrutide was provided for ‘compassionate use’

https://www.statnews.com/2026/06/23/eli-lilly-unusual-weight-loss-drug-trial-compassionate-use-retatrutide-trump/ By Lizzy LawrenceJune 23, 2026 FDA Reporter